Ganymed Pharmaceuticals Announces CE Marking for Test to Assess Claudin-18.2 Expression in Solid Tumors
Ganymed Pharmaceuticals announced today that it has fully developed and obtained CE marking for its in vitro diagnostic…
Ganymed Pharmaceuticals announced today that it has fully developed and obtained CE marking for its in vitro diagnostic…
Die Jerini AG hat heute einen Vertrag über den Verkauf ihrer Tochtergesellschaft JPT Peptide Technologies GmbH an die Th…